Works cited by this work

76 works

Work: Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems

1. Myricetin: A Dietary Molecule with Diverse Biological Activities

   Deepak Kumar Semwal, Ruchi Badoni Semwal, Sandra Combrinck +1

   Review article20163 citations

   ABIABI:AkademIndex/openalex/2026.other.128218

2. Gastrointestinal stability of dihydromyricetin, myricetin, and myricitrin: an <i>in vitro</i> investigation

   Dong Xiang, Chenguang Wang, Wenqing Wang +4

   Article20173 citations

   ABIABI:AkademIndex/openalex/2026.other.128222

3. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

   Tingjuan Ni, Na Lin, Wenqiang Lu +4

   Article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.128235

4. Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism

   Joshua Silva, Xin Yu, Renita Moradian +6

   Article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.128236

5. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability

   Dan Liu, Yiqin Mao, Lijun Ding +1

   Review article20192 citations

   ABIABI:AkademIndex/openalex/2026.other.128228

6. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1

   Zhenzhu Sun, Wenqiang Lu, Na Lin +6

   Article20202 citations

   ABIABI:AkademIndex/openalex/2026.other.128232

7. Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice

   Dafeng Yang, Zhousheng Yang, Lei Chen +15

   Article20202 citations

   ABIABI:AkademIndex/openalex/2026.other.128237

8. Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis

   Quancheng Cheng, Jing Fan, Xin-Wei Deng +6

   Article20202 citations

   ABIABI:AkademIndex/openalex/2026.other.128240

9. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism

   Sijing Dong, Min Zhu, Ke Wang +5

   Article20212 citations

   ABIABI:AkademIndex/openalex/2026.other.128245

10. Dihydromyricetin alleviates Escherichia coli lipopolysaccharide-induced hepatic injury in chickens by inhibiting the NLRP3 inflammasome

    Chenxi Shi, Jiaqi Wang, Ruichen Zhang +7

    Article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.128254

11. Dihydromyricetin prevents obesity <i>via</i> regulating bile acid metabolism associated with the farnesoid X receptor in <i>ob</i>/<i>ob</i> mice

    Yanjun Song, Le Sun, Pei Ma +2

    Article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.128256

12. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

    Xiaoqi Li, Xin Wang, Binyu Wang +7

    Article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.128257

13. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer

    Jiajun Wu, Zuowei Xiao, Hongfang Li +6

    Review article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.128262

14. Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease

    Hang Gong, Huimei Xu, Muyang Li +1

    Review article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.128267

15. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis

    Zheming Xu, Minjing Zhang, Wenwen Wang +19

    Article20232 citations

    ABIABI:AkademIndex/openalex/2026.other.128281

16. Preparation, characterization and protective effect of chitosan - Tripolyphosphate encapsulated dihydromyricetin nanoparticles on acute kidney injury caused by cisplatin

    Qiaohua Yan, Meiqing Li, Liying Dong +12

    Article20232 citations

    ABIABI:AkademIndex/openalex/2026.other.128283

17. Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury

    Doaa Emad, Asmaa M. A. Bayoumi, Sahar M. Gebril +2

    Article20242 citations

    ABIABI:AkademIndex/openalex/2026.other.128289

18. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128214

19. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128215

20. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128216

21. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128217

22. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128219

23. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128220

24. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128221

25. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.128223